EUVIMEDEUVIMED entdecken
Crossref

Ivermectin: Is It to Be a Potent Therapeutic Option for COVID-19?

Shweta Sinha, Alka Sehgal, Rakesh Sehgal

Clinical Infection and Immunity · 2020

DOI: 10.14740/cii106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infection and Immunity, 2020. Verfasst von Shweta Sinha und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Sinha, S., Sehgal, A., & Sehgal, R. (2020). Ivermectin: Is It to Be a Potent Therapeutic Option for COVID-19?. Clinical Infection and Immunity. https://doi.org/10.14740/cii106

Vancouver

Sinha S, Sehgal A, Sehgal R. Ivermectin: Is It to Be a Potent Therapeutic Option for COVID-19?. Clinical Infection and Immunity. 2020. doi:10.14740/cii106

BibTeX
@article{Sinha2020,
  author = {Sinha, Shweta and Sehgal, Alka and Sehgal, Rakesh},
  title = {Ivermectin: Is It to Be a Potent Therapeutic Option for COVID-19?},
  journal = {Clinical Infection and Immunity},
  year = {2020},
  doi = {10.14740/cii106}
}
Kostenlos starten →